80 related articles for article (PubMed ID: 6973856)
1. Maturation of cytotoxic effector cells at the site of allograft rejection.
Ascher NL; Chen S; Hoffman R; Simmons RL
Transplant Proc; 1981 Mar; 13(1 Pt 2):1105-7. PubMed ID: 6973856
[No Abstract] [Full Text] [Related]
2. Migratory behavior of lymphocytes during allograft rejection.
Hoffman RA; Ascher NL; Simmons RL
Transplant Proc; 1981 Mar; 13(1 Pt 2):1102-4. PubMed ID: 7022923
[No Abstract] [Full Text] [Related]
3. Mechanism of allograft rejection in New Zealand mice. II. Role of a serum factor.
Gelfand MC; Parker LM; Steinberg AD
J Immunol; 1974 Jul; 113(1):1-8. PubMed ID: 4598887
[No Abstract] [Full Text] [Related]
4. Cytotoxic T cells play no essential role in acute rejection of orthotopic corneal allografts in mice.
Yamada J; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):386-92. PubMed ID: 11157871
[TBL] [Abstract][Full Text] [Related]
5. The chemokine receptor CCR7 controls lymph node-dependent cytotoxic T cell priming in alloimmune responses.
Höpken UE; Droese J; Li JP; Joergensen J; Breitfeld D; Zerwes HG; Lipp M
Eur J Immunol; 2004 Feb; 34(2):461-70. PubMed ID: 14768051
[TBL] [Abstract][Full Text] [Related]
6. A three-cell model of MLI responsiveness.
Howe M; Cohen L
Transplant Proc; 1976 Sep; 8(3):375-9. PubMed ID: 136074
[No Abstract] [Full Text] [Related]
7. Activation and migration of allo-peptide specific TCR transgenic T cells in cardiac allograft rejection.
Honjo K; Xu XY; Kapp JA; Bucy RP
Cell Immunol; 2004 Jul; 230(1):44-55. PubMed ID: 15541718
[TBL] [Abstract][Full Text] [Related]
8. The role of cytotoxic T lymphocytes in corneal allograft rejection.
Hegde S; Niederkorn JY
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3341-7. PubMed ID: 11006223
[TBL] [Abstract][Full Text] [Related]
9. The migration of activated murine T lymphocytes in vitro. II. Evidence for differential locomotion of T cell subsets.
Hoffman RA; Ascher NL; Hanto DW; Simmons RL
J Immunol; 1983 Apr; 130(4):1610-5. PubMed ID: 6601129
[TBL] [Abstract][Full Text] [Related]
10. Immunological disease induced by injecting F1 lymphoid cells into certain parental strains.
Simpson E; O'Hopp S; Harrison M; Mosier D; Melief K; Cantor H
Immunology; 1974 Dec; 27(6):989-1007. PubMed ID: 4156027
[TBL] [Abstract][Full Text] [Related]
11. The role of T cells in allografted tumor rejection: IFN-gamma released from T cells is essential for induction of effector macrophages in the rejection site.
Yoneda Y; Yoshida R
J Immunol; 1998 Jun; 160(12):6012-7. PubMed ID: 9637516
[TBL] [Abstract][Full Text] [Related]
12. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
Margenthaler JA; Flye MW
J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
[TBL] [Abstract][Full Text] [Related]
13. Effect of alloantibodies on corneal allograft survival.
Hegde S; Mellon JK; Hargrave SL; Niederkorn JY
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1012-8. PubMed ID: 11923241
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells.
Emmanouilidis N; Guo Z; Dong Y; Newton-West M; Adams AB; Lee ED; Wang J; Pearson TC; Larsen CP; Newell KA
Transplantation; 2006 Feb; 81(3):455-62. PubMed ID: 16477234
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of graft rejection by LPS: further evidence for effects on T lymphocytes.
Winchurch RA; Hilberg C; Birmingham W; Munster AM
J Reticuloendothel Soc; 1982 Jan; 31(1):31-42. PubMed ID: 6977643
[TBL] [Abstract][Full Text] [Related]
16. Alloantigen-induced, T-cell-dependent production of nitric oxide by macrophages infiltrating skin allografts in mice.
Krulová M; Zajícová A; Fric J; Holán V
Transpl Int; 2002 Mar; 15(2-3):108-16. PubMed ID: 11935167
[TBL] [Abstract][Full Text] [Related]
17. The role of cytotoxic T lymphocyte projections in target cell lysis.
Rosen D; Fishelson Z; Berke G
Transplant Proc; 1981 Mar; 13(1 Pt 2):1073-8. PubMed ID: 6973855
[No Abstract] [Full Text] [Related]
18. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
[TBL] [Abstract][Full Text] [Related]
19. Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice.
Dai Z; Konieczny BT; Baddoura FK; Lakkis FG
J Immunol; 1998 Aug; 161(4):1659-63. PubMed ID: 9712028
[TBL] [Abstract][Full Text] [Related]
20. Deletion of DOCK2, a regulator of the actin cytoskeleton in lymphocytes, suppresses cardiac allograft rejection.
Jiang H; Pan F; Erickson LM; Jang MS; Sanui T; Kunisaki Y; Sasazuki T; Kobayashi M; Fukui Y
J Exp Med; 2005 Oct; 202(8):1121-30. PubMed ID: 16230477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
